476 related articles for article (PubMed ID: 36010693)
1. Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance.
Hashimoto S; Hashimoto A; Muromoto R; Kitai Y; Oritani K; Matsuda T
Cells; 2022 Aug; 11(16):. PubMed ID: 36010693
[TBL] [Abstract][Full Text] [Related]
2. Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation.
Zhou J; Qu Z; Sun F; Han L; Li L; Yan S; Stabile LP; Chen LF; Siegfried JM; Xiao G
Cancer Immunol Res; 2017 Mar; 5(3):257-268. PubMed ID: 28108629
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.
Kim BH; Yi EH; Ye SK
Arch Pharm Res; 2016 Aug; 39(8):1085-99. PubMed ID: 27515050
[TBL] [Abstract][Full Text] [Related]
4. Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map.
Huynh J; Chand A; Gough D; Ernst M
Nat Rev Cancer; 2019 Feb; 19(2):82-96. PubMed ID: 30578415
[TBL] [Abstract][Full Text] [Related]
5. Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment.
Piperi C; Papavassiliou KA; Papavassiliou AG
Cells; 2019 Nov; 8(11):. PubMed ID: 31698775
[TBL] [Abstract][Full Text] [Related]
6. Histone lactylation inhibits RARγ expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling.
Li XM; Yang Y; Jiang FQ; Hu G; Wan S; Yan WY; He XS; Xiao F; Yang XM; Guo X; Lu JH; Yang XQ; Chen JJ; Ye WL; Liu Y; He K; Duan HX; Zhou YJ; Gan WJ; Liu F; Wu H
Cell Rep; 2024 Feb; 43(2):113688. PubMed ID: 38245869
[TBL] [Abstract][Full Text] [Related]
7. Highlighted STAT3 as a potential drug target for cancer therapy.
Lee H; Jeong AJ; Ye SK
BMB Rep; 2019 Jul; 52(7):415-423. PubMed ID: 31186087
[TBL] [Abstract][Full Text] [Related]
8. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ
Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187
[TBL] [Abstract][Full Text] [Related]
9. Epithelial gp130/Stat3 functions: an intestinal signaling node in health and disease.
Ernst M; Thiem S; Nguyen PM; Eissmann M; Putoczki TL
Semin Immunol; 2014 Feb; 26(1):29-37. PubMed ID: 24434062
[TBL] [Abstract][Full Text] [Related]
10. IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung.
Jing B; Wang T; Sun B; Xu J; Xu D; Liao Y; Song H; Guo W; Li K; Hu M; Zhang S; Ling J; Kuang Y; Zhang T; Zhou BP; Yao F; Deng J
Cancer Res; 2020 Feb; 80(4):784-797. PubMed ID: 31848193
[TBL] [Abstract][Full Text] [Related]
11. Possible Therapeutic Applications of Targeting STAP Proteins in Cancer.
Matsuda T; Oritani K
Biol Pharm Bull; 2021; 44(12):1810-1818. PubMed ID: 34853263
[TBL] [Abstract][Full Text] [Related]
12. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.
Fan Y; Mao R; Yang J
Protein Cell; 2013 Mar; 4(3):176-85. PubMed ID: 23483479
[TBL] [Abstract][Full Text] [Related]
13. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 3 signaling in tumor immune evasion.
Zhang L; Kuca K; You L; Zhao Y; Musilek K; Nepovimova E; Wu Q; Wu W; Adam V
Pharmacol Ther; 2022 Feb; 230():107969. PubMed ID: 34450232
[TBL] [Abstract][Full Text] [Related]
15. STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis.
Jones LM; Broz ML; Ranger JJ; Ozcelik J; Ahn R; Zuo D; Ursini-Siegel J; Hallett MT; Krummel M; Muller WJ
Cancer Res; 2016 Mar; 76(6):1416-28. PubMed ID: 26719528
[TBL] [Abstract][Full Text] [Related]
16. Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression.
Jin J; Li Y; Zhao Q; Chen Y; Fu S; Wu J
Cell Commun Signal; 2021 May; 19(1):50. PubMed ID: 33957948
[TBL] [Abstract][Full Text] [Related]
17. STAT3 can serve as a hit in the process of malignant transformation of primary cells.
Demaria M; Misale S; Giorgi C; Miano V; Camporeale A; Campisi J; Pinton P; Poli V
Cell Death Differ; 2012 Aug; 19(8):1390-7. PubMed ID: 22402588
[TBL] [Abstract][Full Text] [Related]
18. IL22 Promotes
Khosravi N; Caetano MS; Cumpian AM; Unver N; De la Garza Ramos C; Noble O; Daliri S; Hernandez BJ; Gutierrez BA; Evans SE; Hanash S; Alekseev AM; Yang Y; Chang SH; Nurieva R; Kadara H; Chen J; Ostrin EJ; Moghaddam SJ
Cancer Immunol Res; 2018 Jul; 6(7):788-797. PubMed ID: 29764837
[TBL] [Abstract][Full Text] [Related]
19. Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma.
Zhou J; Chng WJ
Cells; 2022 Mar; 11(6):. PubMed ID: 35326392
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
